Inflammatory Burden of Cardiac Allograft Coronary Atherosclerotic Plaque Is Associated With Early Recurrent Cellular Rejection and Predicts a Higher Risk of Vasculopathy Progression

Journal of the American College of Cardiology

Volumn 53, Issue 15, 2009, Pages 1279-1286

  Raichlin, Eugenia ^a   Bae, Jang Ho ^a   Kushwaha, Sudhir S ^a   Lennon, Ryan J ^a   Prasad, Abhiram ^a   Rihal, Charanjit S ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

cardiac transplantation; coronary allograft; intravascular ultrasound; rejection; vasculopathy

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART GRAFT; HEART MUSCLE BIOPSY; HIGH RISK PATIENT; HISTOLOGY; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PLAQUE FORMING CELL; PRIORITY JOURNAL; RISK FACTOR; TISSUE CHARACTERIZATION; VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND;

ADULT; AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 63549125193     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.041     Document Type: Article

References (53)

1. Miller L.W., Schlant R.C., Kobashigawa J., Kubo S., and Renlund D.G. 24th Bethesda conference: cardiac transplantation. Task Force 5: complications. J Am Coll Cardiol 22 (1993) 41-54
2. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
3. Julius B.K., Attenhofer Jost C.H., Sutsch G., et al. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation 69 (2000) 847-853
4. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744-753
5. Pethig K., Heublein B., Kutschka I., and Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 102 (2000) III233-III236
6. Hognestad A., Endresen K., Wergeland R., et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 42 (2003) 477-482
7. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100-2104
8. Raichlin E., Bae J.H., Khalpey Z., et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 116 (2007) 2726-2733
9. Arbustini E., and Roberts W.C. Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease). Am J Cardiol 78 (1996) 814-820
10. Higuchi M.L., Benvenuti L.A., Demarchi L.M., and Libby P. Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis. Transplantation 67 (1999) 1569-1576
11. White J.A., Pflugfelder P.W., Boughner D.R., and Kostuk W.J. Validation of a three-dimensional intravascular ultrasound imaging technique to assess atherosclerotic burden: potential for improved assessment of cardiac allograft coronary artery disease. Can J Cardiol 19 (2003) 1147-1153
12. Bae J.H., Rihal C.S., Edwards B.S., et al. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation 82 (2006) 1108-1111
13. Kapadia S.R., Ziada K.M., L'Allier P.L., et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant 19 (2000) 167-172
14. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., and Vince D.G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
15. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47 (2006) 2405-2412
16. Rodriguez-Granillo G.A., Garcia-Garcia H.M., Mc Fadden E.P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 46 (2005) 2038-2042
17. Valgimigli M., Rodriguez-Granillo G.A., Garcia-Garcia H.M., et al. Plaque composition in the left main stem mimics the distal but not the proximal tract of the left coronary artery: influence of clinical presentation, length of the left main trunk, lipid profile, and systemic levels of C-reactive protein. J Am Coll Cardiol 49 (2007) 23-31
18. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108 (2003) 1772-1778
19. Ehara S., Kobayashi Y., Yoshiyama M., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110 (2004) 3424-3429
20. Bae J.H., Kwon T.G., Hyun D.W., Rihal C.S., and Lerman A. Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart 94 (2008) 1559-1564
21. Kawaguchi R., Oshima S., Jingu M., et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol 50 (2007) 1641-1646
22. Kawamoto T., Okura H., Koyama Y., et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol 50 (2007) 1635-1640
23. Kushwaha S.S., Khalpey Z., Frantz R.P., et al. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 24 (2005) 2129-2136
24. Raichlin E., Khalpey Z., Kremers W., et al. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 84 (2007) 467-474
25. Kobashigawa J.A., Miller L., Yeung A., et al., Sandoz/CVIS Investigators. Does acute rejection correlate with the development of transplant coronary artery disease?. A multicenter study using intravascular ultrasound. J Heart Lung Transplant 14 (1995) S221-S226
26. Raichlin E., Edwards B.S., Kremers W.K., et al. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant (2009) In press.
27. Chaves A.J., Sousa A.G., Mattos L.A., et al. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial. Circulation 109 (2004) 861-866
28. Nair A., Kuban B.D., Obuchowski N., and Vince D.G. Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. Ultrasound Med Biol 27 (2001) 1319-1331
29. Nasu K., Tsuchikane E., Katoh O., et al. Plaque characterization by virtual histology intravascular ultrasound analysis in type II diabetic patients. Heart 94 (2008) 429-433
30. Konig A., Margolis M.P., Virmani R., Holmes D., and Klauss V. Technology insight: in vivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis. Nat Clin Pract Cardiovasc Med 5 (2008) 219-229
31. Virmani R., Burke A.P., Kolodgie F.D., and Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15 (2002) 439-446
32. Johnson D.E., Gao S.Z., Schroeder J.S., DeCampli W.M., and Billingham M.E. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 8 (1989) 349-359
33. Tuzcu E.M., Berkalp B., De Franco A.C., et al. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol 27 (1996) 832-838
34. Hornick P., Smith J., Pomerance A., et al. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of "early" transplant-associated coronary artery disease. Circulation 96 (1997) II148-II153
35. Jimenez J., Kapadia S.R., Yamani M.H., et al. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant 20 (2001) 393-398
36. Brunner-La Rocca H.P., Schneider J., Kunzli A., Turina M., and Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation 65 (1998) 538-543
37. Caforio A.L., Tona F., Fortina A.B., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4 (2004) 962-970
38. Opelz G. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 29 (1997) 73-76
39. Narrod J., Kormos R., Armitage J., Hardesty R., Ladowski J., and Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant 8 (1989) 418-420 discussion 420-1.
40. Vassalli G., Gallino A., Weis M., et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24 (2003) 1180-1188
41. Yamani M.H., Haji S.A., Starling R.C., et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol 39 (2002) 970-977
42. Kobashigawa J.A. First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation. J Heart Lung Transplant 22 (2003) 711-714
43. Labarrere C.A., Lee J.B., Nelson D.R., Al-Hassani M., Miller S.J., and Pitts D.E. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 360 (2002) 1462-1467
44. Sawada T., Shite J., Shinke T., et al. [Relationship between high sensitive C-reactive protein and coronary plaque component in patients with acute coronary syndrome: Virtual Histology study]. J Cardiol 48 (2006) 141-150
45. Raichlin E.R., McConnell J.P., Lerman A., et al. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant 26 (2007) 826-833
46. Rodriguez-Granillo G.A., Serruys P.W., Garcia-Garcia H.M., et al. Coronary artery remodelling is related to plaque composition. Heart 92 (2006) 388-391
47. Burke A.P., Kolodgie F.D., Zieske A., et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24 (2004) 1266-1271
48. Konig A., Kilian E., Rieber J., et al. Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis. J Heart Lung Transplant 27 (2008) 26-30
49. Botas J., Pinto F.J., Chenzbraun A., et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 92 (1995) 1126-1132
50. Li H., Tanaka K., Anzai H., et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol 47 (2006) 2470-2476
51. Sharples L.D., Jackson C.H., Parameshwar J., Wallwork J., and Large S.R. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 76 (2003) 679-682
52. Kapadia S.R., Ziada K.M., L'Allier P.L., et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. J Heart Lung Transplant 19 (2000) 167-172
53. Klauss V., Rieber J., Uberfuhr P., Theisen K., and Mudra H. Qualitative and quantitative assessment of cardiac allograft vasculopathy by intravascular ultrasound. Transplant Proc 27 (1995) 1975-1976